PTIX - Protagenic Therapeutics, Inc.\new
0.74
-0.560 -75.676%
Share volume: 1,922,073
Last Updated: 01-02-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.20%
PREVIOUS CLOSE
CHG
CHG%
$1.30
-0.56
-0.43%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2026 | |
| Report Date | 05-15-2024 | 08-14-2024 | 11-14-2024 | 05-13-2025 | 11-26-2025 | |
| Assets | ||||||
| Total Assets | 2.579 M | 1.467 M | 1.508 M | 988.650 K | 5.003 M | |
| Current Assets | 2.468 M | 1.369 M | 1.423 M | 928.176 K | 2.858 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 1.075 K | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 1.592 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 831.778 K | 924.596 K | 1.056 M | 872.960 K | 2.722 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 110.761 K | 98.189 K | 85.618 K | 60.474 K | 51.407 K | |
| Other Assets | 0.000 | 0.000 | 0.000 | 0.000 | 2.093 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||
| Total Liabilities and shareholders’ equity | 2.579 M | 1.467 M | 1.508 M | 988.650 K | 5.003 M | |
| Total liabilities | 446.095 K | 674.559 K | 789.320 K | 1.077 M | 9.703 M | |
| Total current liabilities | 446.095 K | 674.559 K | 789.320 K | 1.077 M | 9.703 M | |
| Accounts Payable | 446.095 K | 674.559 K | 789.320 K | 1.077 M | 1.641 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 2.132 M | 792.518 K | 719.007 K | -88.329 K | -4.701 M | |
| Common stock | 34.721 M | 35.031 M | 35.599 M | 37.785 M | 6.845 M | |
| Retained earnings | -32.502 M | -34.109 M | -34.749 M | -37.743 M | -11.325 M |